Efficacy and safety of inhalation budesonide in the treatment of pediatric asthma in the emergency department: a systematic review and meta-analysis.

CONCLUSION: The outcomes of the meta-analysis suggest that high-dose inhalation BUD could benefit the pediatric patients in minimizing the worsening of asthma and hospitalization rate, along with improving the pulmonary functions, with negligible adverse drug reactions. PMID: 32227295 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32227295?dopt=Abstract

Source: Pharmacological Reports - March 28, 2020 Category: Drugs & Pharmacology Authors: Viswanatha GL, Shylaja H, Nandakumar K, Venkataranganna MV, Prasad NBL Tags: Pharmacol Rep Source Type: research